Evidence map›Paper›PMID 30268766›Full record

ArticleExperimental neurology2019

Self-reinforcing effects of mTOR hyperactive neurons on dendritic growth.

Salwa R Arafa, Candi L LaSarge, Raymund Y K Pun, Shadi Khademi, Steve C Danzer

Abstract read
In one paragraph

Article in Experimental neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. PTEN DELETION IN THE ADULT DENTATE GYRUS INDUCES EPILEPSY.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. mTOR-Dependent Spine Dynamics in Autism.Frontiers in molecular neuroscience · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PTEN in Autism and Neurodevelopmental Disorders.Cold Spring Harbor perspectives in medicine · 2019
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Salwa R ArafaDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States; Department of Drug Development, James L Winkle College of Pharmacy, University of Cincinnati, OH 45267, United States.
Candi L LaSargeDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States.
Raymund Y K PunDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States.
Shadi KhademiDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States.
Steve C DanzerDepartment of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States; Departments of Anesthesia and Pediatrics, University of Cincinnati, Cincinnati, OH 45267, United States. Electronic address: steve.danzer@cchmc.org.
Cincinnati Children's Hospital Medical Center · US

Funding

Selective disruption of hippocampal dentate granule cells in autism: impact of PTR01NS065020 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI DANZER, STEVE C · 2009 to 2023
$6.1M
mTOR regulation of aberrant neuronal integration and epileptogenesis in epilepsyR01NS062806 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI DANZER, STEVE C · 2009 to 2019
$3.6M
Contribution of abnormal granule cells to the development of an epileptic hippocaF32NS083239 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI LASARGE, CANDI LYNN · 2013 to 2013
$49k
NINDS NIH HHS F32 NS083239NINDS NIH HHS R01 NS062806NINDS NIH HHS R01 NS065020
6 · The paper itself

Abstract

Loss of the mTOR pathway negative regulator PTEN from hippocampal dentate granule cells leads to neuronal hypertrophy, increased dendritic branching and aberrant basal dendrite formation in animal models. Similar changes are evident in humans with mTOR pathway mutations. These genetic conditions are associated with autism, cognitive dysfunction and epilepsy. Interestingly, humans with mTOR pathway mutations often present with mosaic disruptions of gene function, producing lesions that range from focal cortical dysplasia to hemimegalanecephaly. Whether mTOR-mediated neuronal dysmorphogenesis is impacted by the number of affected cells, however, is not known. mTOR mutations can produce secondary comorbidities, including brain hypertrophy and seizures, which could exacerbate dysmorphogenesis among mutant cells. To determine whether the percentage or "load" of PTEN knockout granule cells impacts the morphological development of these same cells, we generated two groups of PTEN knockout mice. In the first, PTEN deletion rates were held constant, at about 5%, and knockout cell growth over time was assessed. Knockout cells exhibited significant dendritic growth between 7 and 18 weeks, demonstrating that aberrant dendritic growth continues even after the cells reach maturity. In the second group of mice, PTEN was deleted from 2 to 37% of granule cells to determine whether deletion rate was a factor in driving this continued growth. Multivariate analysis revealed that both age and knockout cell load contributed to knockout cell dendritic growth. Although the mechanism remains to be determined, these findings demonstrate that large numbers of mutant neurons can produce self-reinforcing effects on their own growth.

Indexed as

AnimalsDendritesMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNeuronsPTEN PhosphohydrolaseRandom AllocationTOR Serine-Threonine KinasesmTOR protein, mousePTEN PhosphohydrolasePten protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID30268766
PMCPMC6263818
OpenAlexW2892748605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.